跳至主要内容
临床试验/DRKS00033692
DRKS00033692招募中不适用

Echottrack: A Prospective Echocardiography-Study On Participants With Heart Failure That Fit The Age-Group For Transthyretin-Amyloidosis To Track The Frequency Of Echo-Red- Flags. - ECHOTTRACK

Pfizer Pharma GmbH0 个研究点目标入组 1,000 人开始时间: 2024年4月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65 Years 至 one(—)
性别
All

入选标准

  • Signed, written informed consent
  • -Signs and symptoms of chronic heart failure

排除标准

  • -Confirmed diagnosis of ATTR-CM (transthyretin amyloid cardiomyopathy)
  • -Chronic heart failure with NYHA IV classification
  • -Participants that are not able to sign the informed consent by themselves.
  • -Participants who are employees of Pfizer or the study site and their family members.

研究者

相似试验